Drug news
FDA approves first generic Lexapro for Depression and Anxiety Disorder
The FDA has approved the first generic version of Lexapro (escitalopram tablets) to treat Depression and generalised Anxiety Disorder in adults. The generic is produced by Teva Pharmaceutical Industries/IVAX Pharmaceuticals who will be marketing generic escitalopram in 5 milligram, 10 mg, and 20 mg strengths. Teva has been granted a 180-day period of generic drug exclusivity, which means that FDA cannot approve another generic version of escitalopram tablets before the end of that period.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins